Cargando…
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
BACKGROUND: To evaluate the clinical utility of LIM Domain Only 2 (LMO2) negative and CD38 positive in diagnosis of Burkitt lymphoma (BL). METHODS: LMO2 and CD38 expression determined by immunohistochemistry in 75 BL, 12 High-grade B-cell lymphoma, NOS (HGBL,NOS) and 3 Burkitt-like lymphomas with th...
Autores principales: | Liu, Yifei, Bian, Tingting, Zhang, Yanlin, Zheng, Yuanyuan, Zhang, Jianguo, Zhou, Xiaoge, Xie, Jianlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727582/ https://www.ncbi.nlm.nih.gov/pubmed/31484540 http://dx.doi.org/10.1186/s13000-019-0876-3 |
Ejemplares similares
-
Intraoral Burkitt's lymphoma in an HIV positive patient
por: Ajila, Vidya, et al.
Publicado: (2012) -
Genes associated with diagnosis and prognosis of Burkitt lymphoma
por: Doughan, Albert, et al.
Publicado: (2022) -
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
por: Vazquez, Ivonne, et al.
Publicado: (2020) -
Burkitt Lymphoma in the Mouse
por: Kovalchuk, Alexander L., et al.
Publicado: (2000) -
Burkitt Lymphoma of the Duodenum
por: Matsueda, Katsunori, et al.
Publicado: (2017)